Aroa Biosurgery logo

ARX - Aroa Biosurgery Share Price

A$1.03 -0.0  -1.9%

Last Trade - 18/06/21

Small Cap
Market Cap £167.7m
Enterprise Value £-425.9m
Revenue £496.7m
Position in Universe 523rd / 1914
Unlock ARX Revenue
Relative Strength (%)
1m -12.8%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -41.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 511.2 1,109 1,150 21.9 31.0 +50.0%
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 September 2020, AroaBiosurgery Ltd revenues decreased 30% to NZ$9.2M. Net lossincreased from NZ$876K to NZ$13.5M. Revenues reflectRoyalty Income - Business decrease from NZ$3M to NZ$0K,Revenue - Balancing value decrease of 10% to NZ$9M. Highernet loss reflects Selling and administrative expensesincrease of 41% to NZ$9.9M (expense), Foreign currencygains decrease from NZ$1.4M (income) to NZ$710K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ARX Revenue Unlock ARX Revenue

Net Income

ARX Net Income Unlock ARX Revenue

Normalised EPS

ARX Normalised EPS Unlock ARX Revenue

PE Ratio Range

ARX PE Ratio Range Unlock ARX Revenue

Dividend Yield Range

ARX Dividend Yield Range Unlock ARX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ARX EPS Forecasts Unlock ARX Revenue
Profile Summary

Aroa Biosurgery Limited is a New Zealand-based soft tissue repair company. The Company is engaged in commercializing regenerative tissue substitutes for medical conditions where impaired healing leads to serious consequences for patients. It designs and manufactures medical products which enable surgeons and clinicians to repair serious tissue injuries. The Company’s solutions include Endoform platform, Wound Care Portfolio and Reinforced Bioscaffolds. The Endoform platform is a building block for developing a range of regenerative tissue substitutes to assist with tissue repair and healing. Its wound care products comprise extracellular matrix to manage acute and chronic wounds. The Reinforced Bioscaffolds combine the biologics and synthetics to address the surgical ventral hernia repair solutions.

Last Annual March 31st, 2020
Last Interim September 30th, 2020
Incorporated September 21, 2007
Public Since July 24, 2020
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P/ASX All Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 300,074,925
Free Float (0.0%)
Eligible for
ARX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ARX
Upcoming Events for ARX
Tuesday 23rd November, 2021 Estimate
Half Year 2022 Aroa Biosurgery Ltd Earnings Release
Frequently Asked Questions for Aroa Biosurgery
What is the Aroa Biosurgery share price?

As of 18/06/21, shares in Aroa Biosurgery are trading at A$1.03, giving the company a market capitalisation of £167.7m. This share price information is delayed by 15 minutes.

How has the Aroa Biosurgery share price performed this year?

Shares in Aroa Biosurgery are currently trading at A$1.03 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Aroa Biosurgery price has moved by % over the past year.

What are the analyst and broker recommendations for Aroa Biosurgery?

Of the analysts with advisory recommendations for Aroa Biosurgery, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Aroa Biosurgery is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Aroa Biosurgery next release its financial results?

Aroa Biosurgery is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Aroa Biosurgery dividend yield?

Aroa Biosurgery does not currently pay a dividend.

Does Aroa Biosurgery pay a dividend?

Aroa Biosurgery does not currently pay a dividend.

When does Aroa Biosurgery next pay dividends?

Aroa Biosurgery does not currently pay a dividend.

How do I buy Aroa Biosurgery shares?

To buy shares in Aroa Biosurgery you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Aroa Biosurgery?

Shares in Aroa Biosurgery are currently trading at A$1.03, giving the company a market capitalisation of £167.7m.

Where are Aroa Biosurgery shares listed? Where are Aroa Biosurgery shares listed?

Here are the trading details for Aroa Biosurgery:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: ARX
What kind of share is Aroa Biosurgery?

Based on an overall assessment of its quality, value and momentum, Aroa Biosurgery is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Aroa Biosurgery share price forecast 2021?

Shares in Aroa Biosurgery are currently priced at A$1.03. At that level they are trading at 93.27% discount to the analyst consensus target price of 0.00.

Analysts covering Aroa Biosurgery currently have a consensus Earnings Per Share (EPS) forecast of -0.0368820166 for the next financial year.

How can I tell whether the Aroa Biosurgery share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aroa Biosurgery. Over the past six months, the relative strength of its shares against the market has been -15.01%. At the current price of A$1.03, shares in Aroa Biosurgery are trading at -14.9% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Aroa Biosurgery PE Ratio?

We were not able to find PE ratio data for Aroa Biosurgery.

Who are the key directors of Aroa Biosurgery?

We were unable to find the directors for Aroa Biosurgery.

Who are the major shareholders of Aroa Biosurgery?

Here are the top five shareholders of Aroa Biosurgery based on the size of their shareholding:

Ward (Brian) Individual Investor
Percentage owned: 11% (33.1m shares)
Movac Ltd Investment Advisor
Percentage owned: 6.2% (18.7m shares)
McCaw (Philip) Individual Investor
Percentage owned: 5.58% (16.8m shares)
Abbott (Richard) Individual Investor
Percentage owned: 3.85% (11.6m shares)
Aspire NZ Seed Fund Ltd. Corporation
Percentage owned: 3.43% (10.3m shares)
Similar to ARX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.